Market Cap 151.46M P/E - EPS this Y -29.00% Ern Qtrly Grth -
Income -31.81M Forward P/E -4.61 EPS next Y 33.30% 50D Avg Chg -28.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -55.00%
Dividend N/A Price/Book 4.20 EPS next 5Y - 52W High Chg -76.00%
Recommedations 3.00 Quick Ratio 3.76 Shares Outst. 35.72M 52W Low Chg 12.00%
Insider Own 19.78% ROA -68.53% Shares Float 31.54M Beta 0.21
Inst Own 22.78% ROE -273.75% Short Shares 0 Price 4.24
Gross Margin - Profit Margin - Avg. Volume 1,193,628 Target Price 17.50
Oper. Margin - Earnings May 5 Volume 979,965 Change 0.71%
Brainstorm Cell Therapeutics In News
02/24/21 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLI
02/24/21 Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Brainstorm Cell Therapeutics Inc. (BCLI) Investigation
02/23/21 BrainStorm to Present at SVB Leerink 10th Global Healthcare Conference
02/22/21 FDA Concludes BrainStorm's ALS Cell Therapy Lacks Substantial Data For Submission; Shares Drop
02/22/21 BrainStorm Announces High-Level FDA Feedback on NurOwn® ALS Clinical Development Program
02/09/21 BrainStorm Announces Feedback from FDA Type-C Meeting on Future NurOwn® Manufacturing Plan
02/06/21 We Think Brainstorm Cell Therapeutics (NASDAQ:BCLI) Needs To Drive Business Growth Carefully
02/05/21 BCLI: Waiting for Guidance from FDA on Potential Path Forward for NurOwn® in ALS…
02/04/21 Why BrainStorm Cell Therapeutics Blasted 27.7% Higher Today
02/04/21 BrainStorm Announces Full Year 2020 Financial Results and Provides a Corporate Update
06:10 AM BCLI: Preclinical Data Shows NurOwn®-Derived Exosomes Effective in ARDS Model…
01/20/21 BrainStorm Announces the Publication of Preclinical Data Highlighting the Potential of a NurOwn® Derived Exosome-Based Treatment for COVID-19 ARDS
12/28/20 BrainStorm Issues 2020 Letter to Shareholders
12/18/20 BrainStorm Announces Completion of All Dosing in NurOwn® Phase 2 MS Study
12/14/20 BrainStorm Announces NurOwn® Expanded Access Program
12/08/20 Need To Know: Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Insiders Have Been Buying Shares
11/26/20 Hedge Funds Aren’t Crazy About Brainstorm Cell Therapeutics Inc. (BCLI) Anymore
11/23/20 BrainStorm to present NurOwn® Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
11/19/20 BCLI: Phase 3 ALS Trial Does Not Meet Primary Endpoint…

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. The company holds rights to develop and commercialize its NurOwn technology that utilizes a patient's own cells, which are engineered outside the body, to produce and secrete factors known to promote neuronal survival. It is developing NurOwn for various neurodegenerative diseases, including its lead indication, which is in Phase III clinical trial for the treatment of amyotrophic lateral sclerosis, as well as in Phase II for the treatment of multiple sclerosis, and preclinical trial for Parkinson's disease, Huntington's disease, and autism spectrum disorder. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004 to reflect its new line of business in the development of novel cell therapies for neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York.

BCLI Chatroom

User Image RBlue Posted - 1 minute ago

$BCLI I checked clinicaltrials.gov https://clinicaltrials.gov/ct2/show/NCT04681118?term=NurOwn&cond=ALS&draw=2&rank=3. It seems like the Expanded Access program trial is still going. Can anyone confirm this? possibly more data? If it's discontinued, then I think that signals that ALS is being put on a backburner. Any information on EAP?

User Image MrMagooooooo Posted - 1 hour ago

$BCLI the market is all over the place. I was expecting this to be down in premarket and my other positions to be up. 😶

User Image SmcTrader77 Posted - 5 hours ago

$AGRX $BBI $BCDA $BCLI $BDSI < IDRA > is announcing their ph-3 data from refractory melanoma next month, huge potential in near term. Click the link below only if you are interested to know more , otherwise ignore plz --h https://www.investorvillage.com/smbd.asp?mb=6268&mn=1710&pt=msg&mid=21737511

User Image BiotechMasterInvestor Posted - 8 hours ago

$BCLI curious if the MS trial that we will hear about next month, does it consist of patients with early MS? Also are they rapid progressors? Im curious if the patients were not early ms, then maybe this will be a repeat of ALS ? Same question whether the patients enrolled in the trial are rapid progressors?

User Image Guygt Posted - 10 hours ago

$BCLI Also, hi Deitz!

User Image Guygt Posted - 10 hours ago

$BCLI anyone know the possibility of getting approval in EU or Israel, despite the recent FDA push back?

User Image AshvsEvilDead Posted - 11 hours ago

$BCLI Has anyone tried reaching out to Dr. Kessler?! I just found out about this. Didn’t know Biden brought him back but would LOVE to get his input on Nurown. https://www.nytimes.com/2021/01/15/health/covid-vaccine-kessler.html

User Image AshvsEvilDead Posted - 11 hours ago

$BCLI $GME picking up again. The FDA has declared certain death for thousands of ALS patients for recommending against a treatment that hit its goal of 35% in newly diagnosed patients. Even stopped progression! We will not stop fighting to save lives! There is a huge story unfolding here and a ticket to 200 would certainly expedite some media attention. #NurOwnWorks

User Image RicoDamango Posted - 13 hours ago

$BCLI https://www.facebook.com/groups/NOMOREEXCUSESALS/permalink/539434370332292/?sfnsn=mo

User Image chiefmoney Posted - 13 hours ago

$BCLI do the results of phase 3 where early diagnosed patients had best results conflict with the phase 2 where they saw better response from rapid progressors?

User Image Stockuponthedip Posted - 14 hours ago

$BCLI brianstorm is going ho back up due to investigation lol like qs

User Image Daniash12 Posted - 15 hours ago

$BCLI these lawyers are no better than ALSA or Janet Woodcock. Purely chasing their self serving asses.

User Image Marcky Posted - 16 hours ago

$BCLI "Stock-drop lawsuits" are common after a stock drops in price. https://grbj.com/blogs/blog-law/beware-of-stock-drop-litigation-during-times-of-crisis/ https://www.bloomberg.com/opinion/articles/2014-06-23/there-will-always-be-stock-drop-lawsuits The Supreme Court has said this about stock-drop lawsuits: "Such class actions, they say, allow plaintiffs to extort large settlements from defendants for meritless claims; punish innocent shareholders, who end up having to pay settlements and judgments; impose excessive costs on businesses; and consume a disproportionately large share of judicial resources"

User Image matt1926 Posted - 16 hours ago

$BCLI - can anyone shed light on this "investigation?"

User Image fla Posted - 16 hours ago

$BCLI [15s. delayed]: Issued Press Release on February 24, 15:51:00: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf o https://s.flashalert.me/XLYj3

User Image ChartMill Posted - 16 hours ago

$BCLI: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brainstorm Cell Therape ... https://www.chartmill.com/stock/quote/BCLI/news?utm_source=stocktwits&utm_medium=pressRelease&utm_content=BCLI&utm_campaign=social_tracking

User Image Ashkenazi91 Posted - 16 hours ago

$BCLI They don’t go into details , they can’t just press release to destroy reputation or share price. That itself would be SEC violation on their part. I wonder if I call, will they tell me?

User Image bigboypants5150 Posted - 17 hours ago

$BCLI I have a strong feeling we are being looked at for purchase. Especially at the current price.

User Image STCKPRO Posted - 17 hours ago

$BCLI NEW ARTICLE : Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Brainstorm Cell Therapeutics Inc. (BCLI) Investigation https://www.stck.pro/news/BCLI/11225354

User Image cctranscripts Posted - 17 hours ago

Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Brainstorm Cell Therapeutics Inc. (BCLI) Investigation http://www.conferencecalltranscripts.org/summary/?id=161107&pr=true $BCLI

User Image bballandstocks Posted - 17 hours ago

$BCLI anyone know what this investigation is about?

User Image fla Posted - 17 hours ago

$BCLI [15s. delayed]: Issued Press Release on February 24, 14:50:00: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Investors of Brainsto https://s.flashalert.me/T3R5n2

User Image Newsfilter Posted - 17 hours ago

$BCLI Bronstein, Gewirtz & Grossman, Notifies Investors of Brainstorm Cell Therapeutics Investigation https://newsfilter.io/a/a9579587836bb24e39e021ecb9492fc7

User Image Stock_Titan Posted - 17 hours ago

$BCLI Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Brainstorm Cell Therapeutics Inc. (BCLI) Investigation https://www.stocktitan.net/news/BCLI/bronstein-gewirtz-grossman-llc-notifies-investors-of-brainstorm-cell-4y1zjemzj84k.html

User Image Balespur Posted - 18 hours ago

$BCLI swinging from here

User Image Reily1 Posted - 19 hours ago

$BCLI it’s funny to see people, like MarketMax, who chastised me for saying Chaim should resign and let Kern run the company now saying the exact same thing! Lol

User Image bbo2020 Posted - 19 hours ago

$BCLI So they have to wait even though it is proven to help those with mild to moderate ALS. Shame on the FDA they will wait till others hit severe stage where there is little help. Someone needs to work on their compassion.

User Image Day9297 Posted - 19 hours ago

$BCLI stocks worthless now hoping for a dead cat bounce

User Image chiefmoney Posted - 20 hours ago

$BCLI FDA is heartless to do that to PALS. Why not provide a 2 year conditional approval and collect data in meantime as they treat PALS? Crazy cruel;

User Image Jpgaresche Posted - 21 hours ago

$BCLI If the bears are 100% correct why isn’t this stock still dipping ? Shouldn’t there be a pretty decent dip after that “horrible” news??